Preeclampsia, a leading cause of preterm birth and maternal/fetal death, occurs in 5-8% of pregnancies and results in billions of annual healthcare costs in the US alone. Diagnosis using current guidelines (hypertension with proteinuria after week 20 of pregnancy) often occurs too late for effective management and intervention. Studies have demonstrated earlier monitoring and intervention can lead to delays in preterm birth as well as decreases in the incidence of preeclampsia.
Carmenta is actively working with Maternal Fetal Medicine specialists (MFMs), OB GYNs, and healthcare economists to develop tests with the value of identifying preeclampsia in both symptomatic and asymptomatic mothers.
7 Symptoms every pregnant mother should know
Awareness Saves Lives